• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

Page 2 of 12
L?Oreal SA Chief Executive Officer Jean-Paul Agon
FinanceL’Oreal Is Snapping Up These 3 Brands from Valeant for $1.3 Billion
By Reuters and Michelle TohJanuary 10, 2017
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
FinanceThese Are the 7 Biggest Hedge Fund Disasters of 2016
By Jen WiecznerDecember 27, 2016
Squawk Box - Season 20
LeadershipBill Ackman Says Valeant Might Change Its Name to Fix Its Reputation
By ReutersNovember 11, 2016
Valeant Pharmaceuticals International Inc's new chief executive Joseph Papa answers questions from shareholders during their annual general meeting in Laval
HealthValeant Has Been Subpoenaed Over Its Pharmacy Activities
By ReutersNovember 10, 2016
Valeant Pharmaceuticals International Inc's new chief executive Joseph Papa speaks to the press following their annual general meeting in Laval
FinanceWhy Valeant Can’t “Dig Out of That Hole” Fast Enough
By Jen WiecznerNovember 8, 2016
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
FinanceValeant Shares Flop After Reporting Smaller-Than-Expected Profits
By ReutersNovember 8, 2016
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
HealthValeant Is Being Sued Over the ‘Female Viagra’ Pill
By Reuters and Tekendra ParmarNovember 2, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
FinanceHere’s Why Valeant Selling Salix Was a Huge Surprise to the Stock Market
By Jen WiecznerNovember 1, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
FinanceHere’s Why Valeant’s Shares Just Plunged, Again
By ReutersOctober 31, 2016
HealthHow Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes
By Sy MukherjeeOctober 17, 2016
CNBC Events
HealthAllergan’s CEO Just Pledged a ‘Social Contract’ With Patients on Drug Prices
By Sy MukherjeeSeptember 6, 2016
Key Speakers At The 20th Annual Sohn Investment Conference
FinanceBill Ackman’s Hedge Fund Is Making Money Again on Valeant’s Rebound
By ReutersSeptember 2, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
FinanceWhat Mylan’s EpiPen Cost Scandal Says About the Drug Price Problem
By Jen WiecznerAugust 25, 2016
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
FinanceValeant Is Said to Be Hiring This Zoetis Exec as Its New CFO
By Reuters and Michelle TohAugust 22, 2016
Female Sex Pill
HealthValeant’s Female Libido Pill Just Got Some Really Low Ratings
By Ed Silverman and STAT NewsAugust 18, 2016
1
  • 1
  • 2
  • 3
  • 4
  • 5
...12
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.